Role of Cardiac Magnetic Resonance Imaging in the Detection of Cardiac Amyloidosis

JACC: Cardiovascular Imaging

Volumn 3, Issue 2, 2010, Pages 155-164

  Syed, Imran S ^a   Glockner, James F ^a   Feng, DaLi ^a   Araoz, Philip A ^a   Martinez, Matthew W ^a   Edwards, William D ^a   Gertz, Morie A ^a   Dispenzieri, Angela ^a   Oh, Jae K ^a   Bellavia, Diego ^a   Tajik, A Jamil ^b   Grogan, Martha ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

amyloidosis; cardiac magnetic resonance; cardiomyopathy

Indexed keywords

AMYLOID; BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; TROPONIN T;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTRIC POTENTIAL; ELECTROCARDIOGRAM; FEMALE; HEART AMYLOIDOSIS; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS;

AGED; AMYLOIDOSIS; BIOLOGICAL MARKERS; BIOPSY; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 75949091211     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.09.023     Document Type: Article

References (24)

1. Falk R.H. Diagnosis and management of the cardiac amyloidoses. Circulation 112 (2005) 2047-2060
2. Falk R.H., Comenzo R.L., and Skinner M. The systemic amyloidoses. N Engl J Med 337 (1997) 898-909
3. Dispenzieri A., Gertz M.A., Kyle R.A., et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 104 (2004) 1881-1887
4. Dubrey S.W., Cha K., Anderson J., et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 91 (1998) 141-157
5. Kyle R.A., Greipp P.R., and O'Fallon W.M. Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. Blood 68 (1986) 220-224
6. Roberts W.C., and Waller B.F. Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. Am J Cardiol 52 (1983) 137-146
7. Smith T.J., Kyle R.A., and Lie J.T. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 59 (1984) 547-555
8. Pellikka P.A., Holmes Jr. D.R., Edwards W.D., Nishimura R.A., Tajik A.J., and Kyle R.A. Endomyocardial biopsy in 30 patients with primary amyloidosis and suspected cardiac involvement. Arch Intern Med 148 (1988) 662-666
9. Cueto-Garcia L., Tajik A.J., Kyle R.A., et al. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc 59 (1984) 589-597
10. Falk R.H., Plehn J.F., Deering T., et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 59 (1987) 418-422
11. Klein A.L., Hatle L.K., Burstow D.J., et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 13 (1989) 1017-1026
12. Klein A.L., Hatle L.K., Taliercio C.P., et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 16 (1990) 1135-1141
13. Maceira A.M., Joshi J., Prasad S.K., et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005) 186-193
14. Perugini E., Rapezzi C., Piva T., et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 92 (2006) 343-349
15. Vogelsberg H., Mahrholdt H., Deluigi C.C., et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51 (2008) 1022-1030
16. Koyama J., Ray-Sequin P.A., and Falk R.H. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107 (2003) 2446-2452
17. Mueller P.S., Edwards W.D., and Gertz M.A. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis. Am J Med 109 (2000) 181-188
18. Cueto-Garcia L., Reeder G.S., Kyle R.A., et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 6 (1985) 737-743
19. Dispenzieri A., Kyle R.A., Gertz M.A., et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 361 (2003) 1787-1789
20. Palladini G., Campana C., Klersy C., et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 107 (2003) 2440-2445
21. Mahrholdt H., Wagner A., Judd R.M., Sechtem U., and Kim R.J. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26 (2005) 1461-1474
22. vanden Driesen R.I., Slaughter R.E., and Strugnell W.E. MR findings in cardiac amyloidosis. AJR Am J Roentgenol 186 (2006) 1682-1685
23. Kwong R.Y., and Falk R.H. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005) 122-124
24. Grosse-Wortmann L., Macgowan C.K., Vidarsson L., and Yoo S.J. Late gadolinium enhancement of the right ventricular myocardium: is it really different from the left?. J Cardiovasc Magn Reson 10 (2008) 20